Inducibility of ? immunoglobulin enhancer-binding protein NF-?B by a posttranslational mechanism, Cell, vol.47, issue.6, pp.921-929, 1986. ,
Roles of the NF-B Pathway in Lymphocyte Development and Function, Cold Spring Harb Perspect Biol, 2010. ,
, , vol.2, pp.182-000182
Nuclear Factor-?B -A Pivotal Transcription Factor in Chronic Inflammatory Diseases, N Engl J Med, vol.336, issue.15, pp.1066-71, 1997. ,
Regulation of cell death and autophagy by IKK and NF-?B: Critical mechanisms in immune function and cancer, Immunol Rev, vol.246, issue.1, pp.327-372, 2012. ,
Aberrant rel/nfkb genes and activity in human cancer ,
, Oncogene, vol.18, pp.6938-6985, 1999.
Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls, Nat Rev Drug Discov [Internet], vol.8, pp.1811-1816, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00352349
Nuclear factor-kappaB in cancer development and progression ,
Nuclear factor-?B inhibitors as sensitizers to anticancer drugs, Nat Rev Cancer, vol.5, issue.4, pp.297-309, 2005. ,
The NF-kappaB family of transcription factors and its regulation, Cold Spring Harb Perspect Biol, vol.1, pp.1-14, 2009. ,
Regulation and function of NF-kappaB transcription factors in the immune system, Annu Rev Immunol, vol.27, pp.693-733, 2009. ,
Malt1-dependent RelB cleavage promotes canonical NF-{kappa}B activation in lymphocytes and lymphoma cell lines, Proc Natl Acad Sci, vol.108, pp.14596-601, 2011. ,
Post-Translational Modifications of RelB NF-?B Subunit and Associated Functions, Cells, vol.5, issue.2, p.22, 2016. ,
Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor ?B and Mitogen-Activated Protein Kinase Pathways. Front Immunol [Internet], vol.9, pp.1-13, 2018. ,
Regulation of death receptor signaling by the ubiquitin system, Cell Death Differ, vol.17, pp.14-24, 2010. ,
The noncanonincal NF-kB pathway, Immunol Rev, vol.246, issue.1, pp.125-165, 2012. ,
Noncanonical NF-?B Signaling in Health and Disease, Trends Mol Med [Internet], vol.22, issue.5, pp.414-443, 2016. ,
Noncanonical NF-?B in Cancer, Biomedicines [Internet], vol.6, issue.2, p.66, 2018. ,
Signalling for B cell survival, Curr Opin Cell Biol [Internet], vol.51, pp.8-14, 2018. ,
Preventing abnormal NF-?B activation and autoimmunity by Otub1-mediated p100 stabilization, Cell Res, vol.29, issue.6, pp.474-85, 2019. ,
The noncanonical NF-kB pathway, Immunol Rev, vol.246, issue.1, pp.125-165, 2012. ,
RelB: an outlier in leukocyte biology, J Leukoc Biol, vol.94, issue.5, pp.941-51, 2013. ,
Transcription of the RelB gene is regulated by NF-?B, Oncogene ,
Multifocal defects in immune responses in RelB-deficient mice, J Immunol, vol.158, issue.11, pp.5211-5218, 1997. ,
IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors ,
URL : https://hal.archives-ouvertes.fr/hal-02411574
, Proc Natl Acad Sci, vol.111, issue.41, pp.14794-14803, 2014.
Frequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple Myeloma, PLoS One, vol.8, issue.3, 2013. ,
RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells, vol.25, pp.1554-1563, 2006. ,
Regulation of p53 and Rb Links the Alternative NF-?B Pathway to EZH2 Expression and Cell, PLoS Genet, vol.10, issue.9, p.1004642, 2014. ,
The RelB subunit of NF?B acts as a negative regulator of circadian gene expression, Cell Cycle, 2012. ,
, , vol.11, pp.3304-3315
RelA repression of RelB activity induces selective gene activation downstream of TNF receptors, Proc Natl Acad Sci, vol.102, issue.41, pp.14635-14675, 2005. ,
Malt1-dependent RelB cleavage promotes canonical NF-B activation in lymphocytes and lymphoma cell lines, Proc Natl Acad Sci, vol.108, issue.35, pp.14596-601, 2011. ,
NF-?B signaling pathway and its potential as a target for therapy in lymphoid neoplasms, Blood Rev, vol.31, issue.2, pp.77-92, 2017. ,
NF-?B and the immune response ,
, Oncogene, vol.25, issue.51, pp.6758-80, 2006.
NF-?B guides the survival and differentiation of developing lymphocytes, Cell Death Differ, 2006. ,
,
Dispensable for B Cell Development, Replaces BAFF-Receptor Signals and Promotes B Cell Proliferation upon Activation ,
RelB is required for Peyer's patch development: Differential regulation of p52-RelB by lymphotoxin and TNF, EMBO J, vol.22, issue.1, pp.121-151, 2003. ,
Lymphoid organ development: from ontogeny to neogenesis, Nat Immunol, 2006. ,
Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule, Immunol Rev, vol.176, issue.1, pp.116-149, 2000. ,
Signaling mechanisms regulating Blymphocyte activation and tolerance, J Mol Med, vol.93, issue.2, pp.143-58, 2015. ,
Apoptosis: a review of programmed cell death, Toxicol Pathol, vol.35, issue.4, pp.495-516, 2007. ,
The molecular machinery of regulated cell death, Cell Res, vol.29, issue.5, pp.347-64, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02125072
Regulation of cell death and autophagy by IKK and NF-?B: critical mechanisms in immune function and cancer, Immunol Rev, vol.246, issue.1, pp.327-372, 2012. ,
Current insights into the regulation of programmed cell death by NF-?B, Oncogene, 2006. ,
, Oct, vol.30, issue.51, pp.6800-6816
Control of apoptosis by Rel/NF-?B transcription factors, Oncogene, vol.18, issue.49, pp.6910-6934, 1999. ,
To be, or not to be: NF-?B is the answer -role of Rel/NF-?B in the regulation of apoptosis, vol.22, pp.8961-82, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00314990
Antiproliferative and antiapoptotic effects of cRel may occur within the same cells via the up-regulation of manganese superoxide dismutase ,
, Cancer Res, vol.61, issue.6, pp.2656-64, 2001.
Nuclear factor-?B induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-?B-dependent transcription in cancer cells, Cancer Res, vol.65, issue.10, pp.4273-81, 2005. ,
NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress, J Biol Chem, 1994. ,
, Aug, vol.5, issue.31, pp.20067-74
Role of NF-?B in p53-mediated programmed cell death, Nature, 2000. ,
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,
Diffuse large B cell lymphomas. Lymphoid Neoplasms 3ed, vol.50, pp.560-86, 2010. ,
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature [Internet], vol.403, issue.6769, pp.503-514, 2000. ,
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma, N Engl J Med, vol.346, issue.25, pp.1937-1984, 2002. ,
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways, Proc Natl Acad Sci, vol.105, issue.36, pp.13520-13525, 2008. ,
Constitutive Nuclear Factor ?B Activity Is Required for Survival of Activated B Cell-like Diffuse Large B Cell Lymphoma Cells, J Exp Med [Internet], vol.194, issue.12, pp.1861-74, 2001. ,
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, vol.103, issue.1, pp.275-82, 2004. ,
Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier, J Mol Diagnostics, 2017. ,
Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay ,
URL : https://hal.archives-ouvertes.fr/hal-02329580
, Haematologica, vol.102, issue.10, pp.404-410, 2017.
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes, Nat Med, vol.24, issue.5, pp.679-90, 2018. ,
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response ,
, , vol.105, pp.1851-61, 2005.
Stromal Gene Signatures in Large-B-Cell Lymphomas, N Engl J Med, vol.359, issue.22, pp.2313-2336, 2008. ,
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma, N Engl J Med [Internet], vol.378, issue.15, pp.1396-407, 2018. ,
Aggressive Lymphomas, N Engl J Med, vol.362, issue.15, pp.1417-1446, 2010. ,
Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma, J Clin Oncol, vol.23, issue.26, pp.6351-6358, 2005. ,
Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: A LYSA study, Clin Cancer Res, vol.22, issue.12, pp.2919-2947, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01343064
An Oncogenic Role for Alternative NF-?B Signaling in DLBCL Revealed upon ,
, Deregulated BCL6 Expression. Cell Rep, vol.11, issue.5, pp.715-741, 2015.
High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma, Blood Rev, vol.31, issue.2, pp.37-42, 2017. ,
B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma, Semin Hematol, 2015. ,
, Apr, vol.52, issue.2, pp.77-85
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies, Haematologica, vol.99, issue.2, pp.222-253, 2014. ,
Oncogenically active MYD88 mutations in human lymphoma, Nature [Internet], vol.470, issue.7332, pp.115-136, 2011. ,
Mutations of multiple genes cause deregulation of NF-B in diffuse large B-cell lymphoma, Nature [Internet], vol.459, issue.7247, pp.717-738, 2009. ,
A multiprotein supercomplex controlling oncogenic signalling in lymphoma, Nature [Internet], vol.560, issue.7718, pp.387-91, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02117984
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-?B, J Clin Invest, vol.107, issue.3, pp.241-247, 2001. ,
,
, Constitutive Canonical NF-?B Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell Lymphoma. Cancer Cell, vol.18, pp.580-589, 2010.
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma, N Engl J Med, vol.346, issue.4, pp.235-277, 2002. ,
,
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte, vol.116, pp.2040-2045, 2010. ,
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial, Lancet ,
Young Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma Benefit From Intensified Chemotherapy With ACVBP Plus Rituximab Compared With CHOP Plus Rituximab: Analysis of Data From the Groupe d'Etudes des Lymphomes de l'Adulte/Lympho, J Clin Oncol, vol.32, issue.35, pp.3996-4003, 2014. ,
Doxorubicin pathways: pharmacodynamics and adverse effects ,
, Pharmacogenet Genomics, vol.21, issue.7, pp.440-446, 2011.
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin ,
Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II-Mediated Form of Cell Death, Cancer Res, vol.66, issue.9, pp.4863-71, 2006. ,
The power and potential of doxorubicin-DNA adducts, IUBMB Life, vol.57, issue.2, pp.73-81, 2005. ,
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation, J Clin Invest, vol.124, issue.2, pp.617-647, 2014. ,
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, Cell Signal, vol.24, issue.5, pp.981-90, 2012. ,
Doxorubicin pathways:pharmacodynamics and adverse effects, Pharmacogenet Genomics [Internet], vol.21, issue.7, pp.440-446, 2012. ,
Ferroptosis as a target for protection against cardiomyopathy, Proc Natl Acad Sci ,
, , vol.116, pp.2672-80, 2019.
The Role of Ferroptosis in Cancer Development and Treatment Response, Front Pharmacol [Internet], vol.8, issue.3, pp.231-238, 2018. ,
Adriamycin dose and time effects on cell cycle, cell death, and reactive oxygen species generation in leukaemia cells, Leuk Res ,
, , vol.36, pp.791-799, 2012.
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience, Adv Ther, vol.34, issue.10, pp.2232-73, 2017. ,
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies, Adv Ther, vol.34, issue.2, pp.324-56, 2017. ,
T-cell-receptor-and B-cell-receptor-mediated activation of NF-?B in lymphocytes, Curr Opin Immunol, vol.16, issue.3, pp.374-81, 2004. ,
Small molecule inhibitors of I?B kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling, Clin Cancer Res, vol.11, issue.1, pp.28-40, 2005. ,
Diffuse large B-cell lymphoma -Treatment approaches in the molecular era, Nat Rev Clin Oncol ,
, , vol.11, pp.12-23, 2014.
,
The biological and clinical impact of inhibition of NF-?B-initiated apoptosis in diffuse large B cell lymphoma (DLBCL), J Pathol, 2011. ,
, , vol.224, pp.355-66
Activation of the NF-?B signalling pathway in diffuse large B-cell lymphoma: Clinical implications, Histopathology, vol.53, issue.4, pp.441-450, 2008. ,
Prognostic impact of C-REL expression in diffuse large B-cell lymphoma, J Hematop, vol.2, issue.1, pp.20-26, 2009. ,
Clinical significance of nuclear factor ?B and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy, Korean J Intern Med [Internet], vol.29, issue.6, p.785, 2014. ,
RelA repression of RelB activity induces selective gene activation downstream of TNF receptors, Proc Natl Acad Sci, vol.102, issue.41, pp.14635-14675, 2005. ,
Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions, Nat Protoc, vol.2, issue.8, pp.1849-61, 2007. ,
Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-?B pathway, Int J Cancer ,
, , vol.136, pp.2341-51, 2015.
NF-?B signaling and its relevance to the treatment of mantle cell lymphoma, J Hematol Oncol, vol.11, issue.1, p.83, 2018. ,
NF-?B deregulation in Hodgkin lymphoma, Semin Cancer Biol [Internet], vol.39, pp.32-41, 2016. ,
MALT lymphoma: many roads lead to nuclear factor-?b activation, Histopathology, vol.58, issue.1, pp.26-38, 2011. ,
,
, Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial, Lancet Oncol, 2019.
Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype, Cancer, vol.117, issue.22, pp.5058-66, 2011. ,
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone, J Clin Oncol, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01609346
, , vol.35, pp.2473-81
A multiprotein supercomplex controlling oncogenic signalling in lymphoma, Nature [Internet], vol.560, issue.7718, pp.387-91, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02117984
,
, Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma, J Clin Oncol, 2019.
Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma, J Exp Clin Cancer Res, vol.38, issue.1, pp.1-16, 2019. ,
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma, Leukemia, 2019. ,
Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma, Blood, vol.131, issue.21, pp.2345-56, 2018. ,
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), Eur J Cancer [Internet], vol.54, pp.11-18, 2016. ,
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. Cancer Cell, vol.29, pp.494-507, 2016. ,
Ciblage de NF-kappaB en oncologie, pp.254-60, 2019. ,
Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study, J Mol Diagnostics, vol.19, issue.6, pp.892-904, 2017. ,
Reliable subtype classification of diffuse large B-cell lymphoma samples 122 from GELA LNH2003 trials using the Lymph2Cx gene expression assay ,
, Haematologica, vol.102, issue.10, pp.404-410, 2017.
Expression of Pitx2 in stromal cells is required for normal hematopoiesis, Blood, vol.107, issue.2, pp.492-500, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00180299
A simple p53 functional assay for screening cell lines, blood, and tumors, Proc Natl Acad Sci, vol.92, issue.9, pp.3963-3970, 1995. ,
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone, J Clin Oncol, vol.30, issue.28, pp.3452-3461, 2012. ,
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone, J Clin Oncol, vol.30, issue.28, pp.3460-3467, 2012. ,
RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells, Cancer Cell Int, vol.18, issue.1, pp.1-16, 2018. ,
?-H2AX -A Novel Biomarker for DNA Doublestrand Breaks, In Vivo (Brooklyn), vol.22, pp.305-315, 2008. ,
Post-translational modification of p53 in tumorigenesis ,
, Nat Rev Cancer, vol.4, issue.10, pp.793-805, 2004.
Cross talk between stimulated NF-?B and the tumor suppressor p53 ,
, Oncogene, vol.29, pp.2795-806, 2010.
Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response, Leuk Lymphoma, 2008. ,
, , vol.49, pp.2170-80
Analysis of the coding genome of diffuse large B-cell lymphoma, Nat Genet, vol.43, issue.9, pp.830-837, 2011. ,
Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival, Blood, vol.120, issue.18, pp.3756-63, 2012. ,
The inhibitors of apoptosis (IAPs) as cancer targets, Apoptosis, vol.12, issue.9, pp.1543-68, 2007. ,
Apoptotic sensitivity of murine IAP-deficient cells, Biochem J ,
, , vol.415, pp.21-26, 2008.
IAPs limit activation of RIP kinases by TNF receptor 1 during development, EMBO J [Internet], vol.31, issue.7, pp.1679-91, 2012. ,
Inhibitor of Apoptosis (IAP) Proteins-Modulators of Cell Death and Inflammation, Cold Spring Harb Perspect Biol, 2013. ,
, Feb, vol.1, issue.2, pp.8730-008730
Cellular inhibitor of apoptosis-2 is a critical regulator of apoptosis in airway epithelial cells treated with asthmarelated inflammatory cytokines, Physiol Rep, vol.1, issue.5, 2013. ,
DNA damage and the balance between survival and death in cancer biology, Nat Rev Cancer, vol.16, issue.1, pp.20-33, 2016. ,
,
, Chromosomal Instability Substantiates Poor Prognosis in Patients with Diffuse Large B-cell Lymphoma, Clin Cancer Res, vol.17, issue.24, pp.7704-7715, 2011.
Identification of the molecular basis of doxorubicin-induced cardiotoxicity, Nat Med, vol.18, issue.11, pp.1639-1681, 2012. ,
The role of cellular reactive oxygen species in cancer chemotherapy, J Exp Clin Cancer Res [Internet], vol.37, issue.1, p.266, 2018. ,
On reactive oxygen species measurement in living systems ,
, J Med Life, vol.8, pp.38-42, 2015.
Inducibility of ? immunoglobulin enhancer-binding protein NF-?B by a posttranslational mechanism, Cell, vol.47, pp.921-928, 1986. ,
Roles of the NF-?B pathway in lymphocyte development and function, Cold Spring Harb. Perspect. Biol, vol.2, pp.1-29, 2010. ,
Nuclear factor-?B-A pivotal transcription factor in chronic inflammatory diseases, N. Engl. J. Med, vol.336, pp.1066-1071, 1997. ,
Regulation of cell death and autophagy by IKK and NF-?B: Critical mechanisms in immune function and cancer, Immunol. Rev, vol.246, pp.327-345, 2012. ,
Aberrant Rel/NF-?B genes and activity in human cancer, Oncogene, vol.18, pp.6938-6947, 1999. ,
NF-?B and cancer-identifying targets and mechanisms, Curr. Opin. Genet. Dev, vol.18, pp.19-26, 2008. ,
Is NF-?B a good target for cancer therapy? Hopes and pitfalls, Nat. Rev. Drug Discov, vol.8, pp.33-40, 2009. ,
Inflammation meets cancer, with NF-?B as the matchmaker, Nat. Immunol, vol.12, pp.715-723, 2011. ,
Nuclear factor factor-?B inhibitors as sensitizers to anticancer drugs, Nat. Rev. Cancer, vol.5, pp.297-309, 2005. ,
The NF-?B family of transcription factors and its regulation, Cold Spring Harb. Perspect. Biol, vol.1, pp.1-14, 2009. ,
Phosphorylation meets ubiquitination: The control of NF-?B activity, Annu. Rev. Immunol, vol.18, pp.621-663, 2000. ,
The noncanonical NF-?B pathway, Immunol. Rev, vol.246, pp.125-140, 2012. ,
The alternative NF-?B activation pathway and cancer: Friend or foe?, Med. Sci, vol.24, pp.1083-1088, 2008. ,
Human RelB (I-Rel) functions as a ? B site-dependent transactivating member of the family of Rel-related proteins, Oncogene, vol.9, pp.1699-1702, 1994. ,
A novel mitogen-inducible gene product related to p50/p105-NF-? B participates in transactivation through a ?B site, Mol. Cell Biol, vol.12, pp.685-695, 1992. ,
RelB, a new Rel family transcription activator that can interact with p50-NF-?B, Mol. Cell Biol, vol.12, pp.674-684, 1992. ,
Both N-and C-terminal domains of RelB are required for full transactivation: Role of the N-terminal leucine zipper-like motif, Mol. Cell Biol, vol.13, pp.1572-1582, 1993. ,
RelA repression of RelB activity induces selective gene activation downstream of TNF receptors, Proc. Natl. Acad. Sci, vol.102, pp.14635-14640, 2005. ,
RelB is required for Peyer's patch development: Differential regulation of p52-RelB by lymphotoxin and TNF, Embo J, vol.22, pp.121-130, 2003. ,
RelB/p50 dimers are differentially regulated by tumor necrosis factor-? and lymphotoxin-? receptor activation: Critical roles for p100, J. Biol. Chem, vol.278, pp.23278-23284, 2003. ,
Activation of IKK? target genes depends on recognition of specific ?B binding sites by RelB:p52 dimers, Embo J, vol.23, pp.4202-4210, 2004. ,
NF-?B p52:RelB heterodimer recognizes two classes of ?B sites with two distinct modes, EMBO Rep, vol.10, pp.152-159, 2009. ,
Shaping alternative NF-?B-dependent gene expression programs: New clues to specificity, Cell Death Differ, vol.13, pp.693-696, 2006. ,
Modulation of NF-?B activity by exchange of dimers, Mol. Cell, vol.11, pp.1563-1574, 2003. ,
RelB is essential for the development of myeloid-related CD8?-dendritic cells but not of lymphoid-related CD8?+ dendritic cells, Immunity, vol.9, pp.839-847, 1998. ,
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-? B/Rel family, Cell, vol.80, pp.331-340, 1995. ,
Multifocal defects in immune responses in RelB-deficient mice, J. Immunol, vol.158, pp.5211-5218, 1997. ,
Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines, J. Immunol, vol.167, pp.1909-1919, 2001. ,
Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent, J. Immunol, vol.157, pp.3974-3979, 1996. ,
Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection, Cell Immunol, vol.274, pp.12-18, 2012. ,
Aryl hydrocarbon receptor signaling regulates NF-?B RelB activation during dendritic-cell differentiation, Immunol. Cell Biol, vol.91, pp.568-575, 2013. ,
Induction of RelB participates in endotoxin tolerance, J. Immunol, vol.177, pp.4080-4085, 2006. ,
Epigenetic Silencing of Tumor Necrosis Factor ? during Endotoxin Tolerance, J. Biol. Chem, vol.282, pp.26857-26864, 2007. ,
The NF-?B factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance, J. Biol. Chem, vol.284, pp.27857-27865, 2009. ,
RelB regulation of chemokine expression modulates local inflammation, Am. J. Pathol, vol.151, pp.375-387, 1997. ,
RelB modulation of I?B? stability as a mechanism of transcription suppression of interleukin-1? (IL-1?), IL-1?, and tumor necrosis factor ? in fibroblasts, Mol. Cell Biol, vol.19, pp.7688-7696, 1999. ,
IKK? and alternative NF-?B regulate PGC-1? to promote oxidative muscle metabolism, J. Cell Biol, vol.196, pp.497-511, 2012. ,
NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance, J. Biol. Chem, vol.286, pp.9856-9864, 2011. ,
RelB: An outlier in leukocyte biology, J. Leukoc. Biol, vol.94, pp.941-951, 2013. ,
The RelB subunit of NFkB acts as a negative regulator of circadian gene expression, Cell Cycle, vol.11, pp.3304-3311, 2012. ,
RelB, a new partner of aryl hydrocarbon receptor-mediated transcription, Mol. Endocrinol, vol.21, pp.2941-3955, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00268250
The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-?B family member RelB, J. Biol. Chem, vol.283, pp.28944-28957, 2008. ,
RelB is the NF-?B subunit downstream of NIK responsible for osteoclast differentiation, Proc. Natl. Acad. Sci, vol.105, pp.3897-3902, 2008. ,
The pivotal role of the alternative NF-?B pathway in maintenance of basal bone homeostasis and osteoclastogenesis, J. Bone Miner. Res, vol.25, pp.809-818, 2010. ,
RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-?B2 processing by IKK?, J. Biol. Chem, vol.289, pp.7349-7361, 2014. ,
Activation of NF-?B and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis, Proc. Natl. Acad. Sci, vol.101, pp.9079-9084, 2004. ,
Frequent engagement of RelB activation is critical for cell survival in multiple myeloma, PLoS ONE, vol.8, 2013. ,
Notch is an essential upstream regulator of NF-?B and is relevant for survival of Hodgkin and Reed-Sternberg cells, Leukemia, vol.26, pp.806-813, 2012. ,
Bone marrow stromal cells prevent apoptosis of lymphoma cells by up regulation of anti-apoptotic proteins associated with activation of NF-?B (RelB/p52) in non-Hodgkin's lymphoma cells, Leukemia, vol.21, pp.1521-1531, 2007. ,
RelB-dependent stromal cells promote T-cell leukemogenesis, PLoS ONE, vol.3, 2008. ,
RelB enhances prostate cancer growth: Implications for the role of the nuclear factor-?B alternative pathway in tumorigenicity, Cancer Res, vol.69, pp.3267-3271, 2009. ,
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2, Nat. Cell Biol, vol.9, pp.470-478, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00145547
The NF-?B RelB protein is an oncogenic driver of mesenchymal glioma, PLoS ONE, vol.8, 2013. ,
Lymphotoxin ? receptor activation promotes bladder cancer in a nuclear factor-?B-dependent manner, Mol. Med. Rep, vol.11, pp.783-790, 2015. ,
NSCLC and the alternative pathway of NF-?B: Uncovering an unknown relation, Virchows Arch, vol.460, pp.515-523, 2012. ,
RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells, Oncogene, vol.25, pp.1554-1559, 2006. ,
Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1?,25-dihydroxyvitamin D(3) in prostate cancer cells, Mol. Cancer Ther, vol.6, pp.2048-2056, 2007. ,
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-?B-inducing kinase (NIK) and noncanonical NF-?B signaling, Mol. Cancer, vol.14, issue.9, 2015. ,
RelB/p52 NF-?B complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor I?B-? expression and promote carcinogenesis of the mammary gland, Mol. Cell Biol, vol.25, pp.10136-10147, 2005. ,
Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation, J. Cell Physiol, vol.220, pp.593-599, 2009. ,
Post-translational modifications regulating the activity and function of the nuclear factor ?B pathway, Oncogene, vol.25, pp.6717-6830, 2006. ,
Posttranslational modifications of NF-?B: Another layer of regulation for NF-?B signaling pathway, Cell Signal, vol.22, pp.1282-1290, 2010. ,
A pervasive role of histone acetyltransferases and deacetylases in an NF-?B-signaling code, Trends Biochem. Sci, vol.33, pp.339-349, 2008. ,
, Regulation by Methylation. Cancer Res, vol.75, pp.3692-3695, 2015.
No one can whistle a symphony alone-How different ubiquitin linkages cooperate to orchestrate NF-?B activity, J. Cell Sci, vol.125, pp.549-559, 2012. ,
Roles of linear ubiquitinylation, a crucial regulator of NF-?B and cell death, in the immune system, Immunol. Rev, vol.266, pp.175-189, 2015. ,
, Cell Mol. Life Sci, vol.64, 1979.
Hierarchies of NF-?B target-gene regulation, Nat. Immunol, vol.12, pp.689-694, 2011. ,
The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration, Mol. Biol. Cell, vol.22, pp.3032-3040, 2011. ,
Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer, Cytokine Growth Factor Rev, vol.26, pp.7-13, 2015. ,
Signal-specific and phosphorylation-dependent RelB degradation: A potential mechanism of NF-?B control, Oncogene, vol.20, pp.8142-8147, 2001. ,
Critical role of RelB serine 368 for dimerization and p100 stabilization, J. Biol. Chem, vol.278, pp.39242-39250, 2003. ,
Identification of lysine residues critical for the transcriptional activity and polyubiquitination of the NF-?B family member RelB, Biochem. J, vol.416, pp.117-127, 2008. ,
IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors, Proc. Natl. Acad. Sci, vol.111, pp.14794-14799, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02411574
SUMOylation attenuates the transcriptional activity of the NF-?B subunit RelB, J. Cell Biochem, vol.115, pp.1430-1440, 2014. ,
Malt1-dependent RelB cleavage promotes canonical NF-?B activation in lymphocytes and lymphoma cell lines, Proc. Natl. Acad. Sci, vol.108, pp.14596-14601, 2011. ,
, , p.28, 2016.
Ubiquitin in the immune system, EMBO Rep, vol.15, pp.28-45, 2014. ,
Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation, Genes Dev, vol.22, pp.998-1010, 2008. ,
Context-specific regulation of NF-?B target gene expression by EZH2 in breast cancers, Mol. Cell, vol.43, pp.798-810, 2011. ,
SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? Genes Dev, vol.18, pp.2046-2059, 2004. ,